Keyphrases
Liver
66%
Hepatopancreatic Ductal System
66%
Hepatopancreatic Duct
66%
Sorafenib
66%
Metabolic Complexity
66%
Gene Therapy
66%
Cancer Causes
66%
Tumor Selectivity
66%
Organic Cation Transporter
66%
Cholangiocarcinoma
66%
Primary Liver Cancer
66%
Metabolism
66%
Metabolic Homeostasis
33%
Promising Biomarkers
33%
Early Diagnosis
33%
Tumor
33%
Metabolic Pathway
33%
Lipid Acids
33%
Amino Acid Uptake
33%
Late Diagnosis
33%
Current Therapies
33%
Liver Disease
33%
Hepatocellular Carcinoma
33%
Clinical Significance
33%
Circulating Metabolites
33%
Hepatocellular Cholangiocarcinoma
33%
Diagnostic Biomarker
33%
High Mortality Rate
33%
Clinical Value
33%
Whole-body Metabolism
33%
Dysregulation
33%
Therapeutic Target
33%
Metabolic
33%
Systems Biology Approach
33%
Early Prognosis
33%
Prognostic Biomarker
33%
Cancer Mortality
33%
Cell Intercalation
22%
Single Lumen
22%
SLC22A1
20%
Medicine and Dentistry
Neoplasm
100%
Cholangiocarcinoma
100%
Liver Cancer
66%
Biological Marker
66%
Morphogenesis
66%
Gene Therapy
66%
Sensitization
66%
Sorafenib
66%
Cancer
40%
Metabolism
33%
Liver Disease
33%
Mortality Rate
33%
Homeostasis
33%
Diagnosis
33%
Hepatocellular Carcinoma
33%
Amino Acid
33%
Early Diagnosis
33%
Metabolite
33%
Malignant Neoplasm
33%
Pancreas Enzyme
16%
Receptor
16%
Cellular Mechanism
16%
Bile
16%
Muscle Contractility
16%
Immunology and Microbiology
Sensitization
66%
Sorafenib
66%
Morphogenesis
66%
Zebra fish
16%
Myosin
16%
Muscle Contractility
16%
Intestine
16%
